Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 12

1.

In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.

Ren G, Webster JM, Liu Z, Zhang R, Miao Z, Liu H, Gambhir SS, Syud FA, Cheng Z.

Amino Acids. 2012 Jul;43(1):405-13. doi: 10.1007/s00726-011-1096-7. Epub 2011 Oct 8.

2.

A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor.

Miao Z, Ren G, Jiang L, Liu H, Webster JM, Zhang R, Namavari M, Gambhir SS, Syud F, Cheng Z.

Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):1977-84. doi: 10.1007/s00259-011-1879-9. Epub 2011 Jul 15.

3.

64Cu-labeled affibody molecules for imaging of HER2 expressing tumors.

Cheng Z, De Jesus OP, Kramer DJ, De A, Webster JM, Gheysens O, Levi J, Namavari M, Wang S, Park JM, Zhang R, Liu H, Lee B, Syud FA, Gambhir SS.

Mol Imaging Biol. 2010 Jun;12(3):316-24. doi: 10.1007/s11307-009-0256-6. Epub 2009 Sep 25.

4.

A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression.

Ren G, Zhang R, Liu Z, Webster JM, Miao Z, Gambhir SS, Syud FA, Cheng Z.

J Nucl Med. 2009 Sep;50(9):1492-9. doi: 10.2967/jnumed.109.064287. Epub 2009 Aug 18.

5.

Engineered two-helix small proteins for molecular recognition.

Webster JM, Zhang R, Gambhir SS, Cheng Z, Syud FA.

Chembiochem. 2009 May 25;10(8):1293-6. doi: 10.1002/cbic.200900062.

PMID:
19422008
6.

Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules.

Cheng Z, De Jesus OP, Namavari M, De A, Levi J, Webster JM, Zhang R, Lee B, Syud FA, Gambhir SS.

J Nucl Med. 2008 May;49(5):804-13. doi: 10.2967/jnumed.107.047381. Epub 2008 Apr 15.

7.

Update: affibody molecules for molecular imaging and therapy for cancer.

Orlova A, Feldwisch J, Abrahmsén L, Tolmachev V.

Cancer Biother Radiopharm. 2007 Oct;22(5):573-84. Review.

PMID:
17979560
8.

Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

Friedman M, Nordberg E, Höidén-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J, Ståhl S.

Protein Eng Des Sel. 2007 Apr;20(4):189-99. Epub 2007 Apr 23.

PMID:
17452435
9.

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.

Tolmachev V, Orlova A, Nilsson FY, Feldwisch J, Wennborg A, Abrahmsén L.

Expert Opin Biol Ther. 2007 Apr;7(4):555-68. Review.

PMID:
17373906
10.

Tumor imaging using a picomolar affinity HER2 binding affibody molecule.

Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Höidén-Guthenberg I, Widström C, Carlsson J, Tolmachev V, Ståhl S, Nilsson FY.

Cancer Res. 2006 Apr 15;66(8):4339-48.

11.

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

Mume E, Orlova A, Larsson B, Nilsson AS, Nilsson FY, Sjöberg S, Tolmachev V.

Bioconjug Chem. 2005 Nov-Dec;16(6):1547-55.

PMID:
16287254
12.

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.

Steffen AC, Wikman M, Tolmachev V, Adams GP, Nilsson FY, Ståhl S, Carlsson J.

Cancer Biother Radiopharm. 2005 Jun;20(3):239-48.

PMID:
15989469

Supplemental Content

Support Center